Oncology has long been a major focus of R&D activities, and it is projected to be the area with the largest proportion of clinical development spending, with 37% of total pipeline expenditure and 28% of total pipeline FDA approvals, over the next 6 years.

Yet, there are many unmet needs for the patient undergoing cancer treatment. Developing improved therapies and providing patients with a choice in the way these therapies are administered are necessary for creating more effective and patient friendly treatments. We see R&D costs are rising and only half of all Phase III drugs reach the market. So how do pharmaceutical companies maximize the chance of their oncology drug being in the right half of that statistic?

This webinar will place the oncology patient and the drug company at the heart of the conversation and will give situational awareness of the challenges both parties face, along with the proven solutions to help overcome these challenges.

Featured Speakers

Peggy Frandolig

Technical Knowledge Manager, Scientific Affairs
West Pharmaceutical Services

Peggy Frandolig holds a Bachelor of Sciences in Biology from the University of Pittsburgh at Johnstown and has over 25 years of experience within the pharmaceutical industry. She currently is the Technical Knowledge Manager in Scientific Affairs where she conducts research and manages complex technical data for packaging and delivery systems and their applications, characteristics, features and claims.  Peggy joined West Pharmaceutical Services in 2000, as Project Coordinator for the Analytical Laboratories; Peggy was promoted to Associate Manager of Project Management and Document Control in the Analytical Labs. She then further her career as Quality Assurance Manager, Customer Relations, her most recent position at West was Director of Technical Customer Support using her knowledge and experience working with customers to guide decisions for appropriate container closure systems for their drug products.

Victoria Morgan

Director, Segment Marketing, Global Biologics
West Pharmaceutical Services

Victoria Morgan has been in the pharmaceutical industry for more than 25 years with extensive experience across primary and secondary care and the area of injection drug delivery products, such as primary packaging and combination products for vial, prefilled syringe systems, cartridges and devices.

Throughout her tenure at West, she has served in various functions across sales and marketing. Victoria spent more than 17 years in global sales roles followed by 3 years as Director of Segment Marketing, Biologics here at West, where she has responsibility for global biologics strategy development and implementation.

Date:  Wednesday, September 30, 2020
Time:  11am ET / 8am PT
Duration:  1 Hour

Register now for this webinar